ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

September 30, 2005

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975

Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story

May 8, 1998

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

In Brief: Boutwell Declines Nomination to New NCAB Term; Rowley Again Urges Appointment Of Scientists

January 20, 1984